Morgan Stanley analyst Ronald Kamdem raised the firm’s price target on American Healthcare REIT (AHR) to $37 from $36 and keeps an Overweight rating on the shares. The firm updated estimates to reflect Q4 earnings and mark to market the multiple based on where healthcare peers have traded, noting that it updated its FY25 and FY26 FFO per share forecasts to $1.57 and $1.77 from $1.63 and $1.78, respectively.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT management to meet with KeyBanc
- American Healthcare REIT Announces Quarterly Distribution
- American Healthcare REIT price target raised to $32 from $30 at Truist
- Strong Financial Position and Growth Potential Drive Buy Rating for American Healthcare REIT, Inc.
- American Healthcare REIT price target raised to $35 from $30 at Citizens JMP